This unorthodox anti-obesity candidate may not warrant inclusion in your table, but here it is anyhow: https://www.globenewswire.com/news-release/2024/04/25/2869629/0/en/Aphaia-Pharma-Provides-Enrollment-and-Protocol-Update-for-Phase-2-Trial-in-Individuals-with-Obesity.html https://www.clinicaltrials.gov/study/NCT05385978 Aphaia Pharma is private.